Latest news
Exploring the Emerging Role of Extracellular Traps in Immune-Mediated Inflammatory Diseases
Earlier this week, Citryll hosted an educational webinar bringing together leading scientific and clinical experts to discuss the evolving understanding
Citryll Strengthens Intellectual Property Portfolio With Grant of European Composition of Matter Patent for CIT-013
Expected to provide exclusivity into 2039 Oss, Netherlands – 15 April 2026 – Citryll, a biotech company pioneering a transformative
First patient dosed in Citryll’s imaging study evaluating distribution and target engagement of CIT-013
PET-based imaging study designed to assess the biodistribution of CIT-013 and associate disease activity with CIT-013 target disposition in participants
Employee Spotlight – Catarina Antunes
As a key part of Citryll’s team, Catarina Antunes, Program & Communications Manager, plays a central role in driving cross‑functional
End of Year Newsletter 2025
As I look back on 2025, it has been a truly remarkable year for the Citryll team. With a laser
First Patient Dosed In Citryll’s Phase IIA Hidradenitis Suppurativa Trial
Multi-center, randomized study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with hidradenitis suppurativa Marks the
Citryll presents positive data from phase I study of CIT-013 in Rheumatoid Arthritis at ACR convergence 2025
Phase I trial data in rheumatoid arthritis patients demonstrates favorable safety, encouraging clinical activity, and robust biomarker responses Data provides
First Patient Dosed In Citryll’s Phase IIA Trial Evaluating CIT-013 In Rheumatoid Arthritis
Randomized multi-center study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with moderately active rheumatoid arthritis
Citryll Announces Formation Of Scientific Advisory Board
Board comprises world-renowned experts in biology, immunology and pathology. Oss, Netherlands – 24 July 2025 – Citryll, a biotech company
Employee Spotlight – Eline Zwiers
Eline Zwiers is a valued member of Citryll’s research team. As a Research Associate, she plays a key role in